Drawing based on the label description. No photo yet.
“Tablets, film-coated: 10 mg of ponatinib: Oval, white to off-white, biconvex, debossed "NZ" on one side and plain on the other side”
NZ pill
Pill with imprint NZ is white, oval, 7 mm and has been identified as Ponatinib Hydrochloride 10 mg. It is used for myeloid leukemia. It is supplied by Takeda Pharmaceuticals America, Inc.
Ponatinib Hydrochloride 10 mg
- Imprint
- NZ
- Strength
- 10 mg
- Used for
- Myeloid leukemia
- Color
- White
- Shape
- Oval
- Size
- 7 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Takeda Pharmaceuticals America, Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 63020-536, 63020-536-30
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Ponatinib Hydrochloride used for?
Ponatinib Hydrochloride is used for myeloid leukemia.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
ICLUSIG® is indicated for the treatment of adult patients with:
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
- Newly diagnosed Ph+ ALL in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
- As monotherapy in Ph+ ALL for whom no other kinase inhibitors are indicated or T315I-positive Ph+ ALL.
Chronic Myeloid Leukemia (CML)
- Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors.
- Accelerated phase (AP) or blast phase (BP) CML for whom no other kinase inhibitors are indicated.
- T315I-positive CML (chronic phase, accelerated phase, or blast phase).
Limitations of Use: ICLUSIG is not indicated and is not recommended for the treatment of patients with newly diagnosed CP-CML.
From the FDA-approved label on DailyMed (published Aug 19, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows NZ and the other side is plain.
- It is white, oval, 7 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Iclusig.
Ingredients
Active: Ponatinib Hydrochloride
Inactive: Lactose Monohydrate, Microcrystalline Cellulose, Sodium Starch Glycolate Type B Potato, Silicon Dioxide, Magnesium Stearate
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
EC
Enalapril Maleate 2.5 mg
White, oval, 8 mm
Used for severe high blood pressure and heart failure
-
R 2 5 0163
Olanzapine 2.5 mg
White, oval, 8 mm
Used for bipolar disorder and schizophrenia
-
G Breakline G
Levocetirizine Dihydrochloride 5 mg
White, oval, 8 mm
Used for hay fever and year-round allergies
-
C 5
Cabergoline 0.5 mg
White, oval, 7 mm
Used for Parkinson's disease and adenoma
-
H 5
Hydrocortisone 5 mg
White, oval, 8 mm
Used for adrenal insufficiency and inflammation
-
F 5 4
Escitalopram Oxalate 10 mg
White, oval, 8 mm
Used for major depressive disorder
Other Ponatinib Hydrochloride pills
- A5 Ponatinib Hydrochloride 15 mg White, round, 6 mm Used for myeloid leukemia
- A5 Ponatinib Hydrochloride 15 mg White, round, 6 mm Used for myeloid leukemia
- C7 Ponatinib Hydrochloride 30 mg White, round, 8 mm Used for myeloid leukemia
- AP4 Ponatinib Hydrochloride 45 mg White, round, 10 mm Used for myeloid leukemia